PeterLabs Holdings Bhd (0171) - Total Liabilities

Latest as of September 2025: RM21.70 Million MYR ≈ $5.45 Million USD

Based on the latest financial reports, PeterLabs Holdings Bhd (0171) has total liabilities worth RM21.70 Million MYR (≈ $5.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PeterLabs Holdings Bhd net asset momentum to track the company's year-over-year net asset growth rate.

PeterLabs Holdings Bhd - Total Liabilities Trend (2015–2024)

This chart illustrates how PeterLabs Holdings Bhd's total liabilities have evolved over time, based on quarterly financial data. See 0171 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

PeterLabs Holdings Bhd Competitors by Total Liabilities

The table below lists competitors of PeterLabs Holdings Bhd ranked by their total liabilities.

Company Country Total Liabilities
Zelan Bhd
KLSE:2283
Malaysia RM524.27 Million
Orion Digital Corp.
NASDAQ:ORIO
USA $100.11 Million
Narmada Agrobase Limited
NSE:NARMADA
India Rs128.11 Million
Bharat Road Network Limited
NSE:BRNL
India Rs10.45 Billion
Digicontent Limited
NSE:DGCONTENT
India Rs2.16 Billion
Gold Pacific Co. Ltd
KQ:038530
Korea ₩8.14 Billion
Puma Exploration Inc
V:PUMA
Canada CA$1.38 Million
Manganese X Energy Corp
V:MN
Canada CA$59.62K

Liability Composition Analysis (2015–2024)

This chart breaks down PeterLabs Holdings Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PeterLabs Holdings Bhd (0171) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.93 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.28 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PeterLabs Holdings Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PeterLabs Holdings Bhd (2015–2024)

The table below shows the annual total liabilities of PeterLabs Holdings Bhd from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 RM34.09 Million
≈ $8.56 Million
-8.23%
2023-12-31 RM37.15 Million
≈ $9.33 Million
+16.63%
2022-12-31 RM31.85 Million
≈ $8.00 Million
-18.63%
2021-12-31 RM39.15 Million
≈ $9.83 Million
+159.78%
2020-12-31 RM15.07 Million
≈ $3.78 Million
-25.62%
2019-12-31 RM20.26 Million
≈ $5.09 Million
-17.46%
2018-12-31 RM24.55 Million
≈ $6.16 Million
+5.89%
2017-12-31 RM23.18 Million
≈ $5.82 Million
+3.87%
2016-12-31 RM22.32 Million
≈ $5.60 Million
+93.89%
2015-12-31 RM11.51 Million
≈ $2.89 Million
--

About PeterLabs Holdings Bhd

KLSE:0171 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$15.89 Million
RM63.30 Million MYR
Market Cap Rank
#25818 Global
#750 in Malaysia
Share Price
RM0.23
Change (1 day)
+0.00%
52-Week Range
RM0.21 - RM0.36
All Time High
RM0.45
About

PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more